M. Trauner's Profile

Role	Title	Level	Year	L/R
🐜	EASL Clinical Practice Guidelines: management of cholestatic liver diseases. 9 auth. U. Beuers, K. Boberg, R. Chapman, O. Chazouilleres, P. Invernizzi, D. Jones, ... F. Lammert, A. Parés, M. Trauner	10	2009	10 🐜
🐜	Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) 24 auth. J. Banales, V. Cardinale, G. Carpino, M. Marzioni, J. Andersen, P. Invernizzi, G. E. Lind, T. Folseraas, S. Forbes, L. Fouassier, ... A. Geier, D. Calvisi, J. Mertens, M. Trauner, A. Benedetti, L. Maroni, J. Vaquero, R. Macías, C. Raggi, M. Perugorria, E. Gaudio, K. Boberg, J. Marin, D. Alvaro	10	2016	10 🐜
🦁	Bile salt transporters: molecular characterization, function, and regulation. M. Trauner, J. Boyer	9	2003	9 🦁
🐜	Detection of Various Microplastics in Human Stool 7 auth. P. Schwabl, Sebastian Kppel, Philipp Knigshofer, T. Bucsics, M. Trauner, T. Reiberger, ... B. Liebmann	9	2019	9 🐜
🐬	The interaction of hepatic lipid and glucose metabolism in liver diseases. L. Bechmann, Rebekka A. Hannivoort, G. Gerken, G. Hotamışlıgil, M. Trauner, A. Canbay	9	2012	9 🐬
🐜	A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis. 32 auth. F. Nevens, P. Andreone, G. Mazzella, S. Strasser, C. Bowlus, P. Invernizzi, J. Drenth, P. Pockros, J. Reguła, U. Beuers, M. Trauner, Dave E. Jones, A. Floreani, S. Hohenester, V. Luketic, ... M. Shiffman, K. V. van Erpecum, V. Vargas, C. Vincent, G. Hirschfield, Hemant A Shah, B. Hansen, K. Lindor, H. Marschall, K. Kowdley, R. Hooshmand-Rad, T. Marmon, S. Sheeron, R. Pencek, L. Macconell, M. Pruzanski, D. Shapiro	9	2016	9 🐜
🐜	Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. 11 auth. K. Panzitt, M. M. Tschernatsch, C. Guelly, T. Moustafa, M. Stradner, H. Strohmaier, ... Charles R. Buck, H. Denk, R. Schroeder, M. Trauner, K. Zatloukal	9	2007	9 🐜
🦁	Molecular pathogenesis of cholestasis. M. Trauner, Peter J. Meier, J. Boyer	9	2012	9 🦁
🐜	ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1 35 auth. G. Haemmerle, T. Moustafa, G. Woelkart, S. Büttner, A. Schmidt, T. Weijer, M. Hesselink, Doris Jaeger, Petra C. Kienesberger, Kathrin A. Zierler, R. Schreiber, Thomas O. Eichmann, D. Kolb, P. Kotzbeck, M. Schweiger, ... M. Kumari, S. Eder, Gabriele Schoiswohl, Nuttaporn Wongsiriroj, N. Pollak, F. Radner, Karina Preiss-Landl, T. Kolbe, T. Rülicke, B. Pieske, M. Trauner, A. Lass, R. Zimmermann, G. Hoefler, S. Cinti, E. Kershaw, P. Schrauwen, F. Madeo, B. Mayer, R. Zechner	9	2011	9 🐜
🐢	Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series 9 auth. S. Lax, Kristijan Skok, P. Zechner, H. Kessler, N. Kaufmann, Camillo Koelblinger, ... K. Vander, Ute Bargfrieder, M. Trauner	9	2020	9 🐢
🐬	Bile acid receptors as targets for drug development F. Schaap, M. Trauner, P. Jansen	9	2014	9 🐬
🐜	Adipose Triglyceride Lipase Contributes to Cancer-Associated Cachexia 15 auth. S. Das, S. Eder, S. Schauer, C. Diwoky, H. Temmel, Barbara Guertl, G. Gorkiewicz, K. P. Tamilarasan, P. Kumari, M. Trauner, ... R. Zimmermann, P. Vesely, G. Haemmerle, R. Zechner, G. Hoefler	9	2011	9 🐜
🐜	Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid. 18 auth. G. Hirschfield, A. Mason, V. Luketic, K. Lindor, S. Gordon, M. Mayo, K. Kowdley, C. Vincent, Henry C. Bodhenheimer, A. Parés, ... M. Trauner, H. Marschall, L. Adorini, Cathi Sciacca, T. Beecher-Jones, E. Castelloe, O. Böhm, D. Shapiro	9	2015	9 🐜